Evidence map›Paper›PMID 31782544›Full record

ArticleThe EMBO journal2020

Zfp281 orchestrates interconversion of pluripotent states by engaging Ehmt1 and Zic2.

Daniela Mayer, Michael B Stadler, Melanie Rittirsch, Daniel Hess, Ilya Lukonin, Maria Winzi, Austin Smith, Frank Buchholz, Joerg Betschinger

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A chemical epigenetic tool to probe site-specific DNA-binding protein complexes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. BRD8 Guards the Pluripotent State by Sensing and Maintaining Histone Acetylation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Daniela MayerFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Michael B StadlerFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Melanie RittirschFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Daniel HessFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Ilya LukoninFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Maria WinziMedical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
Austin SmithWellcome-MRC Cambridge Stem Cell Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3029-4682
Frank BuchholzMedical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.ORCID 0000-0002-4577-3344
Joerg BetschingerFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID 0000-0002-2627-8479
Friedrich Miescher Institute · CHUniversity Hospital Carl Gustav Carus · DEUniversity of Basel · CHSIB Swiss Institute of Bioinformatics · CHWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

EU Seventh Framework Programme Integrated Project SyBoSSMedical Research Council G1100526Novartis Research Foundation
6 · The paper itself

Abstract

Developmental cell fate specification is a unidirectional process that can be reverted in response to injury or experimental reprogramming. Whether differentiation and de-differentiation trajectories intersect mechanistically is unclear. Here, we performed comparative screening in lineage-related mouse naïve embryonic stem cells (ESCs) and primed epiblast stem cells (EpiSCs), and identified the constitutively expressed zinc finger transcription factor (TF) Zfp281 as a bidirectional regulator of cell state interconversion. We showed that subtle chromatin binding changes in differentiated cells translate into activation of the histone H3 lysine 9 (H3K9) methyltransferase Ehmt1 and stabilization of the zinc finger TF Zic2 at enhancers and promoters. Genetic gain-of-function and loss-of-function experiments confirmed a critical role of Ehmt1 and Zic2 downstream of Zfp281 both in driving exit from the ESC state and in restricting reprogramming of EpiSCs. Our study reveals that cell type-invariant chromatin association of Zfp281 provides an interaction platform for remodeling the cis-regulatory network underlying cellular plasticity.

Indexed as

Cell DifferentiationGene Expression RegulationAnimalsCells, CulturedChromatinHistone-Lysine N-MethyltransferaseMiceMouse Embryonic Stem CellsPluripotent Stem CellsTranscription FactorsChromatinGLP protein, mouseHistone-Lysine N-MethyltransferaseTranscription FactorsZfp281 protein, mouseZic2 protein, mousecell state transitioncellular plasticitydifferentiationpluripotencyreprogramming

Identifiers

PMID31782544
PMCPMC6960450
OpenAlexW2990418440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.